Works matching IS 21644403 AND DT 2024 AND VI 14 AND IP 4
Results: 9
SC Nivolumab Could Reduce Disparities in the Care of Patients With Clear Cell Renal Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 4, p. 18
- Publication type:
- Article
KEYNOTE-564: Survival Benefit With Adjuvant Treatment in Clear Cell Renal Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 4, p. 17
- Publication type:
- Article
Cabozantinib-Atezolizumab Improves Radiographic PFS in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 4, p. 16
- Publication type:
- Article
Immunotherapy Plus VEGF Inhibitor Added to TACE Improves PFS in Unresectable HCC.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 4, p. 13
- Publication type:
- Article
Is Adjuvant/Neoadjuvant Immunotherapy Ready for Standard of Care in Resectable GEJ Cancer?
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 4, p. 12
- Publication type:
- Article
FDA Reviews 50 Years of Cannabis Research Related to Drug Development.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 4, p. 10
- Publication type:
- Article
Navigating the Complex Landscape of Oral Cancer Medication: A Multidisciplinary Approach to Patient Care.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 4, p. 8
- Publication type:
- Article
The Efficient Practice: How to Streamline Your Practice.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 4, p. 6
- By:
- Publication type:
- Article
5 Strategies for Managing Patient Scheduling Challenges in an Oncology Practice.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 4, p. 5
- By:
- Publication type:
- Article